To help reduce drug and supply costs for healthcare providers, the HealthTrust Clinical Pharmacy Team identified a conversion from the Solu-Medrol Act-O-Vial System to generic methylprednisolone sodium succinate vials. With a high return on investment, the conversion aims to result in meaningful cost reductions that will more than justify any operational impacts. To assist providers with conversion efforts, HealthTrust created a class review of the methylprednisolone sodium succinate products, as well as a toolkit with operational considerations and recommendations for implementation.
In this course, we will review the conversion, associated cost savings and GPO compliance, as well as how attendees can use the HealthTrust toolkit to benefit their organization.
- Learn key details about the methylprednisolone initiative
- Understand the value of Implementation and cost savings
- Explore HealthTrust tools that aid with conversion
Who Should Attend:
- Pharmacy Directors